Cue Biopharma Ownership | Who Owns Cue Biopharma?


OverviewForecastRevenueFinancialsChartTranscripts

Cue Biopharma Ownership Summary


Cue Biopharma is owned by 15.36% institutional investors, 0.35% insiders, and 84.29% retail investors. Bleichroeder lp is the largest institutional shareholder, holding 9.75% of CUE shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.18% of its assets in Cue Biopharma shares.

CUE Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCue Biopharma15.36%0.35%84.29%
SectorHealthcare Stocks 279.18%10.62%-189.80%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bleichroeder lp5.00M9.75%$5.45M
Vanguard group2.06M4.01%$2.24M
Blackrock756.74K1.53%$938.35K
Blackrock funding, inc. /de638.95K1.25%$696.46K
Geode capital management631.28K1.23%$688.25K
Robertson stephens wealth management478.50K0.93%$521.57K
Sigma planning447.18K0.87%$487.42K
Northern trust350.42K0.71%$434.52K
Advisory research257.23K0.50%$280.38K
Bank of america corp /de/242.57K0.49%$300.78K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bleichroeder lp5.00M1.37%$5.45M
Advisory research257.23K0.05%$280.38K
Robertson stephens wealth management478.50K0.02%$521.57K
Sigma planning447.18K0.02%$487.42K
Gsa capital partners llp149.80K0.01%$163.00K
Xtx topco46.97K0.00%$51.20K
Texas capital bank wealth management services33.10K0.00%$36.08K
Seacrest wealth management13.00K0.00%$14.17K
Gleason group6.00K0.00%$6.54K
Newbridge financial services group3.00K0.00%$3.27K

Top Buyers

HolderShares% AssetsChange
Geode capital management631.28K0.00%122.45K
Blackrock funding, inc. /de638.95K-67.98K
Sigma planning447.18K0.02%45.85K
Hightower advisors128.28K0.00%45.00K
Texas capital bank wealth management services33.10K0.00%33.10K

Top Sellers

HolderShares% AssetsChange
Slate path capital lp---2.40M
Blackrock756.74K--1.49M
Good life advisors---400.00K
Renaissance---274.03K
Monaco asset management sam---253.19K

New Positions

HolderShares% AssetsChangeValue
Texas capital bank wealth management services33.10K0.00%33.10K$36.08K
Golden state wealth management2.00K0.00%2.00K$2.18K
Macquarie group1.80K-1.80K$2.24K
Physician wealth advisors1.01K0.00%1.01K$1.10K
Mai capital management350.00-350.00$382.00

Sold Out

HolderChange
Assetmark-2.00
Nelson, van denburg & campbell wealth management group-7.00
Farther finance advisors-43.00
Citigroup-43.00
Innealta capital-49.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202551-10.53%11,402,706-3.03%152.91%16-48.39%13116.67%
Dec 31, 2024555.77%11,733,877-15.65%223.11%30150.00%6-64.71%
Sep 30, 202451-32.00%13,910,2910.71%273.48%13-61.76%17-15.00%
Jun 30, 202475-5.06%13,812,235-15.72%272.18%3447.83%20-28.57%
Mar 31, 202479-7.06%16,389,05610.09%353.47%23-37.84%2847.37%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.35M2.18%-1.00
Vanguard Total Stock Mkt Idx Inv1.56M2.07%-
Vanguard Institutional Extnd Mkt Idx Tr766.43K1.02%49.23K
Fidelity Extended Market Index352.57K0.47%5.70K
NT R2000 Growth Index Fund - NL103.76K0.17%-
BlackRock Extended Equity Market K103.23K0.17%-44.00
Extended Equity Market Fund K102.14K0.17%313.00
NT R2000 Index Fund - NL89.94K0.15%-9.65K
Fidelity Total Market Index108.58K0.14%-
iShares Micro-Cap ETF99.35K0.13%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 16, 2024PASSERI DANIEL R CHIEF EXECUTIVE OFFICERBuy$30.90K
Aug 25, 2023Suri Anish PRESIDENT AND CSOBuy$11.04K
Aug 14, 2023PASSERI DANIEL R CHIEF EXECUTIVE OFFICERBuy$8.58K
Mar 23, 2023Kiener Peter A-Sell$30.59K
May 27, 2022Morich Frank Buy$105.00K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q41-
2024 Q3--
2024 Q2--

CUE Ownership FAQ


Who Owns Cue Biopharma?

Cue Biopharma shareholders are primarily institutional investors at 15.36%, followed by 0.35% insiders and 84.29% retail investors. The average institutional ownership in Cue Biopharma's industry, Biotech Stocks , is 63.96%, which Cue Biopharma falls below.

Who owns the most shares of Cue Biopharma?

Cue Biopharma’s largest shareholders are Bleichroeder lp (5M shares, 9.75%), Vanguard group (2.06M shares, 4.01%), and Blackrock (756.74K shares, 1.53%). Together, they hold 15.30% of Cue Biopharma’s total shares outstanding.

Does Blackrock own Cue Biopharma?

Yes, BlackRock owns 1.53% of Cue Biopharma, totaling 756.74K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 938.35K$. In the last quarter, BlackRock decreased its holdings by -1.487M shares, a -66.28% change.

Who is Cue Biopharma’s biggest shareholder by percentage of total assets invested?

Bleichroeder lp is Cue Biopharma’s biggest shareholder by percentage of total assets invested, with 1.37% of its assets in 5M Cue Biopharma shares, valued at 5.45M$.

Who is the top mutual fund holder of Cue Biopharma shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Cue Biopharma shares, with 2.18% of its total shares outstanding invested in 1.35M Cue Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools